KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BeOne Medicines (ONC) Non-Current Deferred Tax Liability: 2016-2025

Historic Non-Current Deferred Tax Liability for BeOne Medicines (ONC) over the last 7 years, with Sep 2025 value amounting to $47.1 million.

  • BeOne Medicines' Non-Current Deferred Tax Liability rose 195.36% to $47.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $47.1 million, marking a year-over-year increase of 195.36%. This contributed to the annual value of $42.0 million for FY2024, which is 108.90% up from last year.
  • BeOne Medicines' Non-Current Deferred Tax Liability amounted to $47.1 million in Q3 2025, which was up 6.74% from $44.1 million recorded in Q2 2025.
  • In the past 5 years, BeOne Medicines' Non-Current Deferred Tax Liability registered a high of $47.1 million during Q3 2025, and its lowest value of $10.8 million during Q1 2021.
  • Over the past 3 years, BeOne Medicines' median Non-Current Deferred Tax Liability value was $16.4 million (recorded in 2024), while the average stood at $26.6 million.
  • In the last 5 years, BeOne Medicines' Non-Current Deferred Tax Liability dropped by 18.18% in 2023 and then skyrocketed by 195.36% in 2025.
  • BeOne Medicines' Non-Current Deferred Tax Liability (Quarterly) stood at $14.2 million in 2021, then surged by 73.46% to $24.6 million in 2022, then dropped by 18.18% to $20.1 million in 2023, then surged by 108.90% to $42.0 million in 2024, then skyrocketed by 195.36% to $47.1 million in 2025.
  • Its Non-Current Deferred Tax Liability stands at $47.1 million for Q3 2025, versus $44.1 million for Q2 2025 and $43.1 million for Q1 2025.